Safety study of ICP-538 in healthy volunteers
This trial tests a new drug called ICP-538 in healthy people to see how safe it is and how the body processes it. It is an early-phase study that helps decide if the drug can move to testing in patients with a specific condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy, with no serious medical conditions.
- Your body mass index (BMI) is between 18 and 26.
- If you are a man, you weigh at least 50 kg (about 110 lbs); if a woman, at least 45 kg (about 99 lbs).
- Your vital signs, heart test (ECG), chest X-ray, and abdominal ultrasound are normal or only have minor, non-worrisome findings.
- You agree to use reliable birth control if you or your partner can become pregnant, and men agree not to donate sperm for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.
This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.
This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.
This study tests a new experimental medicine called IBI3042, given as a single dose, to see how safe it is in healthy volunteers. It is an early-phase trial that helps doctors understand if the drug is well-tolerated before testing it in patients.
Hear when a new Health Services Research trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.